Breast cancer is a highly heterogeneous disease and is currently classified into four general molecular subtypes according to the status of hormone receptors, including estrogen receptor (ER) or progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [1]. This evidence concerns the gene ERBB2 and breast carcinoma.